These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10633185)

  • 1. Threshold-mediated mechanisms in mutagenesis: implications in the classification and regulation of chemical mutagens.
    Crebelli R
    Mutat Res; 2000 Jan; 464(1):129-35. PubMed ID: 10633185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory recognition of indirect genotoxicity mechanisms in the European Union.
    Pratt IS; Barron T
    Toxicol Lett; 2003 Apr; 140-141():53-62. PubMed ID: 12676451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reflections on the implications of thresholds of mutagenic activity for the labelling of chemicals by the European Union.
    Parry JM
    Mutat Res; 2000 Jan; 464(1):155-8. PubMed ID: 10633188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective.
    Bolt HM; Foth H; Hengstler JG; Degen GH
    Toxicol Lett; 2004 Jun; 151(1):29-41. PubMed ID: 15177638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Threshold effects in genetic toxicity: perspective of chemicals regulation in Germany.
    Madle S; von der Hude W; Broschinski L; Jänig G
    Mutat Res; 2000 Jan; 464(1):117-21. PubMed ID: 10633183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
    Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
    Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case for a new paradigm in genetic toxicology testing.
    Pottenger LH; Gollapudi BB
    Mutat Res; 2009 Aug; 678(2):148-51. PubMed ID: 19616117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Origin of the linearity no threshold (LNT) dose-response concept.
    Calabrese EJ
    Arch Toxicol; 2013 Sep; 87(9):1621-33. PubMed ID: 23887208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next generation testing strategy for assessment of genomic damage: A conceptual framework and considerations.
    Dearfield KL; Gollapudi BB; Bemis JC; Benz RD; Douglas GR; Elespuru RK; Johnson GE; Kirkland DJ; LeBaron MJ; Li AP; Marchetti F; Pottenger LH; Rorije E; Tanir JY; Thybaud V; van Benthem J; Yauk CL; Zeiger E; Luijten M
    Environ Mol Mutagen; 2017 Jun; 58(5):264-283. PubMed ID: 27650663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interpretation of the biological relevance of genotoxicity test results: the importance of thresholds.
    Kirkland DJ; Müller L
    Mutat Res; 2000 Jan; 464(1):137-47. PubMed ID: 10633186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategy of the scientific committee on occupational exposure limits (SCOEL) in the derivation of occupational exposure limits for carcinogens and mutagens.
    Bolt HM; Huici-Montagud A
    Arch Toxicol; 2008 Jan; 82(1):61-4. PubMed ID: 18008062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-response and threshold-mediated mechanisms in mutagenesis: statistical models and study design.
    Lovell DP
    Mutat Res; 2000 Jan; 464(1):87-95. PubMed ID: 10633180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproductive toxicants have a threshold of adversity.
    Piersma AH; Hernandez LG; van Benthem J; Muller JJ; van Leeuwen FX; Vermeire TG; van Raaij MT
    Crit Rev Toxicol; 2011 Jul; 41(6):545-54. PubMed ID: 21609253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A proposal to improve clarity and communication in the EU Classification process for chemicals for carcinogenicity and reproductive and developmental toxicity.
    Doe JE
    J Appl Toxicol; 2014 Oct; 34(10):1068-72. PubMed ID: 25059745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Series: current issues in mutagenesis and carcinogenesis, No. 65. The genotoxicity and carcinogenicity of paracetamol: a regulatory (re)view.
    Bergman K; Müller L; Teigen SW
    Mutat Res; 1996 Feb; 349(2):263-88. PubMed ID: 8600357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenging dogma: thresholds for genotoxic carcinogens? The case of vinyl acetate.
    Hengstler JG; Bogdanffy MS; Bolt HM; Oesch F
    Annu Rev Pharmacol Toxicol; 2003; 43():485-520. PubMed ID: 12415124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of DNA polymerase ζ mutations on genotoxic thresholds of oxidative mutagens.
    Suzuki T; Matsumoto K; Honma M; Nohmi T
    Mutat Res Genet Toxicol Environ Mutagen; 2018 Apr; 828():10-14. PubMed ID: 29555059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of dose-response data in a margin of exposure approach to carcinogenic risk assessment for genotoxic chemicals in food.
    Benford DJ
    Mutagenesis; 2016 May; 31(3):329-31. PubMed ID: 26297741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International Commission for Protection Against Environmental Mutagens and Carcinogens. The subtlety of alkylating agents in reactions with biological macromolecules.
    Vogel EW; Nivard MJ
    Mutat Res; 1994 Feb; 305(1):13-32. PubMed ID: 7508544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo extrapolations of genotoxin exposures: consideration of factors which influence dose-response thresholds.
    Parry JM; Jenkins GJ; Haddad F; Bourner R; Parry EM
    Mutat Res; 2000 Jan; 464(1):53-63. PubMed ID: 10633177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.